SBAC three-lens brief
Evidence-based stock research on SBAC. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $235.35 — 27% above current (20 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $235.35 — 27% above current (20 analysts).
- Negative free cash flow last quarterly (-$301.85M).
SBAC closed at $185.82 (+1.83%) as of 2026-07-10. Market cap: $19.71B. P/E (trailing) 19.5. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $235.35 — 27% above current (20 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; negative free cash flow last quarterly (-$301.85M).. Last quarter: Revenue $703.44M, net income $184.83M, free cash flow -$301.85M.
Why three lenses on SBAC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine SBACacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/SBAC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath SBAC brief"></iframe>